Reacción #2350946

ord-e70e7eeae9ec486db6d65b5e78462a92

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    OtroPrepared in 55% (338 mg)
  2. 2
    Otroyield

Procedimiento

Prepared in 55% (338 mg) yield as described in general procedure (B) from 4-[1-cyclohexyl-3-(5-formyl-thiazol-2-yl)ureido]-piperidine-1-carboxylic acid tert-butyl ester (436 mg, 1.0 mmol) and piperazine-1-sulfonic acid dimethylamide hydrochloride (230 mg, 1.0 mmol).

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US07851636B2uspto-grants-2010_12